Precigen (PGEN) EBITDA Margin Growth (5y) (2017 - 2026)
Precigen (PGEN) EBITDA Margin Growth (5y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Precigen |
1.32 Bn |
1.32 Bn |
20.69 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
4,639.00 |
| Dec 31, 2025 |
-28,973.00 |
| Jun 30, 2025 |
-9.34 Mn |
| Mar 31, 2025 |
-163,920.00 |
| Dec 31, 2024 |
-156,200.00 |
| Sep 30, 2024 |
-222,584.00 |
| Jun 30, 2024 |
-898,370.00 |
| Mar 31, 2024 |
-1.75 Mn |
| Dec 31, 2023 |
-213,178.00 |
| Sep 30, 2023 |
-209.35 Mn |
| Jun 30, 2023 |
-112,238.00 |
| Mar 31, 2023 |
-714,192.00 |
| Dec 31, 2022 |
23,862.00 |
| Sep 30, 2022 |
-34,434.00 |
| Jun 30, 2022 |
-77,047.00 |
| Mar 31, 2022 |
-34,838.00 |
| Dec 31, 2021 |
27,948.00 |
| Sep 30, 2021 |
-59,189.00 |
| Jun 30, 2021 |
-64,734.00 |
| Mar 31, 2021 |
1,624.00 |
